125 related articles for article (PubMed ID: 1765965)
21. [Penicillamine in the treatment of scleroderma].
Kobíková M; Stáva Z
Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784
[No Abstract] [Full Text] [Related]
22. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
Høyer H; Hvid-Jacobsen K; Weismann K
Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
[TBL] [Abstract][Full Text] [Related]
23. [Effect of penicillin and D-penicillamine on beta-galactosidase activity in patients with progressive scleroderma].
Schulze E; Herrmann K; Haustein UF; Krusche U; Rothenburger I
Dermatol Monatsschr; 1988; 174(11):661-6. PubMed ID: 3145222
[No Abstract] [Full Text] [Related]
24. Treatment of systemic sclerosis.
Medsger TA
Rheum Dis Clin North Am; 1989 Aug; 15(3):513-31. PubMed ID: 2672135
[TBL] [Abstract][Full Text] [Related]
25. (D)-penicillamine treatment in systemic sclerosis (scleroderma). Effect on nutritional capillary circulation.
Mellstedt H; Fagrell B; Holm G; Björkholm M
Scand J Rheumatol; 1977; 6(2):92-6. PubMed ID: 897590
[TBL] [Abstract][Full Text] [Related]
26. Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
Strand V
Arthritis Rheum; 2002 Nov; 46(11):2836-7. PubMed ID: 12428222
[No Abstract] [Full Text] [Related]
27. Nodular scleroderma in systemic sclerosis under D-penicillamine therapy.
Sasaki T; Denpo K; Ono H; Nakajima H
J Dermatol; 1992 Dec; 19(12):968-71. PubMed ID: 1293190
[TBL] [Abstract][Full Text] [Related]
28. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
[TBL] [Abstract][Full Text] [Related]
29. Photochemotherapy in systemic sclerosis. The stage is set.
Trentham DE
Arch Dermatol; 1992 Mar; 128(3):389-90. PubMed ID: 1550373
[No Abstract] [Full Text] [Related]
30. Treatment of scleroderma heart by D-penicillamine.
Muers M; Stokes W
Br Heart J; 1976 Aug; 38(8):864-7. PubMed ID: 135572
[TBL] [Abstract][Full Text] [Related]
31. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia].
Daróczy J; Gyöngyvér S
Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080
[No Abstract] [Full Text] [Related]
32. [Treatment of systemic scleroderma with D-penicillamine. Results in 14 patients treated for more than a year].
Kahn MF; Bourgeois P; Brion N; Elleuch M
Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):35-8. PubMed ID: 3704510
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
Nishikai M; Funatsu Y; Homma M
Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
[No Abstract] [Full Text] [Related]
34. [Recent attempts at treatment of diffuse scleroderma].
Pavelka K
Cas Lek Cesk; 1972; 111(10):221-3. PubMed ID: 5010871
[No Abstract] [Full Text] [Related]
35. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].
Szczepanski A
Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035
[No Abstract] [Full Text] [Related]
36. Penicillamine in systemic sclerosis: a reappraisal.
Sattar MA; Guindi RT; Sugathan TN
Clin Rheumatol; 1990 Dec; 9(4):517-22. PubMed ID: 2088649
[TBL] [Abstract][Full Text] [Related]
37. Penicillamine types in the sclerodermas.
Tio TH
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):78-9. PubMed ID: 122680
[No Abstract] [Full Text] [Related]
38. D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).
Medsger TA
Arthritis Rheum; 1987 Jul; 30(7):832-4. PubMed ID: 3304300
[No Abstract] [Full Text] [Related]
39. Immunological alterations during photopheresis and D-penicillamine treatment of systemic sclerosis.
Rietschel RL; Cooper ES
Ann N Y Acad Sci; 1991 Dec; 636():400-2. PubMed ID: 1793227
[No Abstract] [Full Text] [Related]
40. Does long-term treatment with D-penicillamine alter calcium and phosphorus metabolism in patients with systemic sclerosis?
Hagdrup H; Serup J; Tvedegaard E
Acta Derm Venereol; 1983; 63(5):447-9. PubMed ID: 6197850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
